| WHAT: |
The 9th Annual CFAR (Center for AIDS Research)
Research Symposium: “HIV/AIDS Research 2005: From Innovation
to Intervention” hosted by the Penn Center for
AIDS Research
|
| WHO: |
Internationally recognized speakers, representatives from
the 20 U.S. CFARs, NIH officials and HIV/AIDS investigators
from the University of Pennsylvania, The Children’s
Hospital of Philadelphia, and the Wistar Institute
| 8:35 a.m. |
Dr. Gary J. Nabel, Director
of the Vaccine Research Center, NIH
The Critical Path to an AIDS Vaccine |
| 9:20 a.m. |
Ms. Julie A. Furj, M.S.W., Coordinator
of the Community Advisory Board, Penn CFAR
U.S. Urban Epidemic and “The Community” |
| 10:15 a.m. |
Dr. Harvey Friedman, Director of the
Penn CFAR International Core and Chief of the Division
of Infectious Diseases
The PENN-Botswana Program, Combining Patient Care
and Clinical Research |
| 2:05 p.m. |
Dr. Frederic Bushman, Professor of
Microbiology, University of Pennsylvania School of Medicine
HIV DNA Integration |
| 4:25 p.m. |
Dr. Carl H. June, Director, PENN CFAR
Immunology Core, Professor of Pathology and Laboratory
Medicine, University of Pennsylvania School of Medicine
Lentiviral Gene Transfer for HIV/AIDS |
|
| WHEN: |
Thursday, November 17, 2005
8:15 a.m. - 5:00 p.m.
|
| WHERE: |
University of Pennsylvania School of Medicine
Dunlop Auditorium, Stemmler Hall
3450 Hamilton Walk
Philadelphia, PA 19104 |
BACKGROUND:
The National Institutes of Health established Centers for AIDS Research
(CFARs) for the purpose of creating an interdisciplinary environment
that encourages collaborative efforts among HIV/AIDS investigators
in basic, clinical, behavioral, and social sciences. Currently,
there are 20 CFARs throughout the United States. Senior researchers
from all of the Centers come together each year to attend a National
Research Symposium that highlights recent progress and ongoing challenges
in HIV/AIDS. The Penn CFAR includes over 160 HIV/AIDS investigators
at the University of Pennsylvania, The Children’s Hospital
of Philadelphia, and the Wistar Institute, and supports research
programs in viral pathogenesis, clinical, immunology & vaccine,
and behavioral & social sciences.
###
PENN Medicine is a $2.7 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn’s School of Medicine is ranked #2 in the nation
for receipt of NIH research funds; and ranked #4 in the nation in
U.S. News & World Report’s most recent ranking of top
research-oriented medical schools. Supporting 1,400 fulltime faculty
and 700 students, the School of Medicine is recognized worldwide
for its superior education and training of the next generation of
physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System comprises: its
flagship hospital, the Hospital of the University of Pennsylvania,
consistently rated one of the nation’s “Honor Roll”
hospitals by U.S. News & World Report; Pennsylvania Hospital,
the nation's first hospital; Penn Presbyterian Medical Center; a
faculty practice plan; a primary-care provider network; two multispecialty
satellite facilities; and home health care and hospice.
|